Evidence map›Paper›PMID 33122939›Full record

ArticleJournal of pain research2020

Opioid Medication Use Among Chronic Non-Cancer Pain Patients Assessed with a Modified Drug Effects Questionnaire and the Association with Opioid Use Disorder.

Joseph A Boscarino, Carrie A Withey, Ryan J Dugan, Yirui Hu, Jessica Auciello, Thomas Alfieri

Open access · goldAbstract read
In one paragraph

Article in Journal of pain research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. CDC Clinical Practice Guideline for Prescribing Opioids for Pain - United States, 2022.MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports · 2022
    Guideline
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Joseph A BoscarinoDepartment of Population Health Sciences, Geisinger Clinic, Danville, PA, 17822, USA.ORCID 0000-0002-9965-6805
Carrie A WitheyDepartment of Population Health Sciences, Geisinger Clinic, Danville, PA, 17822, USA.ORCID 0000-0002-8646-701X
Ryan J DuganDepartment of Population Health Sciences, Geisinger Clinic, Danville, PA, 17822, USA.ORCID 0000-0002-4472-783X
Yirui HuDepartment of Population Health Sciences, Geisinger Clinic, Danville, PA, 17822, USA.ORCID 0000-0002-0477-0155
Jessica AucielloMedical Affairs, Purdue Pharma L.P, Stamford, CT 06901, USA.ORCID 0000-0001-8247-7889
Thomas AlfieriMedical Affairs, Purdue Pharma L.P, Stamford, CT 06901, USA.ORCID 0000-0002-0357-497X
Geisinger Health System · USPurdue Pharma (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeIdentifying opioid use disorder (OUD) in patients prescribed opioid therapy for chronic pain is challenging but critically important. Patients may have multiple reasons for taking medications, which they may not reveal if not properly interviewed. In this study, modified Drug Effects Questionnaires (DEQ) were used to assess the liking of and desire to take prescription opioids both for reasons of pain relief and for reasons excluding pain relief. We hypothesized patients would more strongly endorse their medications for reasons of pain relief compared to reasons excluding pain relief, and patients who endorse medications for reasons excluding pain relief may be at higher risk of developing OUD. PATIENTS AND

methodsA cross-sectional telephone survey was administered to 200 adult outpatients currently being prescribed opioids. A two-year retrospective analysis of electronic health records supplemented survey findings.

resultsBased on DSM-5 criteria, 9.0% (n = 18) of patients had moderate or severe OUD. The mean (SD) for drug-liking was 54 (33.4) on a 0 to 100 scale. When liking for pain relief was specified, the mean (SD) was significantly higher compared to when excluding pain relief was specified, 70 (27.8) vs 24 (31.2), p<0.001. A similar pattern was observed for patients' ratings of desire to take their medication again, and "feel good effects" of their medications. Higher scores on items that excluded pain relief were associated with other indications of drug misuse.

conclusionThe observed rate of OUD in this patient sample was consistent with findings from other recent research. A better understanding of patients' reasons for using opioid medication may help researchers and health care providers identify those at greatest risk for developing OUD.

Indexed as

chronic painDSM-5nonmedical opioid useopioidstolerance and withdrawal criteria

Identifiers

PMID33122939
PMCPMC7591039
OpenAlexW3093984162

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.